Delivery Order SPE2DE21D0017-SPE2D625F9XD1
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a delivery order valued at $6,030.30 for BinaxNOW COVID-19 antigen test cards on July 31, 2025, with an ultimate completion date of August 21, 2025. The contract, which carries a fixed-price structure with economic price adjustment provisions, was awarded without a set-aside designation, indicating full and open competition. Performance will be executed in Lockhart, Florida, and the contract is funded through...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $1,407.07 for BinaxNOW COVID-19 antigen test cards. This fixed-price contract with economic price adjustment was awarded on July 25, 2025, with an ultimate completion date of August 15, 2025, and will be performed in Lockhart, Florida. The award was issued without a set-aside designation, indicating open competition. Funding is provided through the Defense Logistics Agency...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on August 18, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $1,206.06. This fixed-price contract with economic price adjustment was funded by the Defense Logistics Agency Medical Supply Chain and will be performed in Lockhart, Florida. The contract represents an open competition award with no set-aside designation and is scheduled for ultimate completion on September...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a delivery order award valued at $4,422.22 on July 30, 2025, for BinaxNOW COVID-19 antigen cards to be delivered to Lockhart, Florida. The contract employs a fixed-price structure with economic price adjustment provisions and carries an ultimate completion date of August 20, 2025. The award was made without a set-aside designation, indicating open competition among qualified vendors. The Defense Logistics...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on August 15, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $2,412.12. This fixed-price contract with economic price adjustment was issued without a set-aside designation, indicating open competition. The award is funded through the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procurement of medical supplies to...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,206.06 on August 22, 2025, for BinaxNOW COVID-19 antigen test cards. This fixed-price contract with economic price adjustment will be performed in Lockhart, Florida, with an ultimate completion date of September 15, 2025. The contract was awarded without a set-aside designation, indicating open competition. The funding source is the Defense Logistics Agency's Medical Supply...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a fixed-price delivery order with economic price adjustment on August 20, 2025, for BinaxNOW COVID-19 antigen test cards with a ceiling value of $1,005.05. The contract, issued without set-aside designation, represents an open competition award and is funded by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for supplying medical equipment and diagnostic...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $6,030.30 fixed-price delivery order contract to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide BinaxNOW COVID-19 antigen test cards. This contract does not have a set-aside designation. The award is part of Abbott's existing indefinite-delivery, indefinite-quantity (IDIQ) contracts with the Department of Veterans Affairs and Department of Defense to supply diagnostic testing products and...
- The Defense Logistics Agency Troop Support Medical awarded Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, a $402,020 delivery order to provide Abbott BinaxNOW COVID-19 antigen test cards. The fixed price with economic price adjustment contract has a period of performance from August 16, 2023 to September 7, 2023. Place of performance will be Abbott's facility located in Lockhart, Florida. The BinaxNOW cards are rapid antigen tests used to detect current COVID-19...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a fixed-price delivery order contract to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide BinaxNOW COVID-19 antigen test cards. The contract has a potential value of $1,005.05 and a completion date of January 22, 2024. This award is not associated with a set-aside program. Abbott Rapid DX North America LLC, also doing business as Alere, is a provider of medical testing equipment, supplies, and...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D625F9XD1Delivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $4,020.20 for BinaxNOW COVID-19 antigen test cards. The contract was awarded on August 1, 2025, with an ultimate completion date of August 22, 2025, under a fixed-price arrangement with economic price adjustment provisions. The award was issued without a set-aside designation, indicating open competition among qualified vendors. The Defense Logistics Agency Medical Supply Chain is the funding federal agency, and performance will take place in Lockhart, Florida. This delivery order represents a task order call against the vendor's existing indefinite delivery vehicles and blanket purchase agreements with federal healthcare agencies, particularly the Veterans Integrated Service Networks. Abbott Rapid DX North America LLC has established itself as a critical supplier of COVID-19 diagnostic products and point-of-care testing solutions to the Department of Defense and Department of Veterans Affairs. The BinaxNOW rapid antigen test cards delivered under this order support ongoing diagnostic and testing needs across federal healthcare facilities, contributing to the government's COVID-19 response and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/1/25 |